Status:
COMPLETED
Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial
Lead Sponsor:
Saint Alphonsus Regional Medical Center
Conditions:
Arthritis Knee
Arthritis of Hip
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Clinicians commonly utilize intraarticular injections to treat symptomatic primary arthritis. Steroid injections are common yet have immune-modulating effects and can alter gene expression which may d...
Eligibility Criteria
Inclusion
- Symptomatic, radiographically proven degenerative joint disease in the hip or knee
Exclusion
- recent injection in the hip or knee within the previous 3 months
- history of traumatic osteoarthritis or ligamentous reconstruction
- chronic narcotic use
- history of inflammatory or neuropathic arthropathy
- pregnant and/or nursing women
- allergy or strong reaction to study medications
Key Trial Info
Start Date :
May 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04441112
Start Date
May 20 2018
End Date
August 20 2019
Last Update
June 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Alphonsus Regional Medical Center
Boise, Idaho, United States, 83706